Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children PDF full book. Access full book title Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children by World Health Organization. Download full books in PDF and EPUB format.
Author: World Health Organization
Publisher:
ISBN: 9789241548748
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
It is estimated that one third of the world's population is infected with Mycobacterium tuberculosis (the bacterium that causes tuberculosis (TB)), and that each year, about 9 million people develop TB, of whom about 2 million die. Of the 9 million annual TB cases, about 1 million (11%) occur in children (under 15 years of age). Of these childhood cases, 75% occur annually in 22 high-burden countries that together account for 80% of the world's estimated incident cases. In countries worldwide, the reported percentage of all TB cases occurring in children varies from 3% to more than 25%. The Stop TB Strategy, which builds on the DOTS strategy developed by the World Health Organization (WHO) and the International Union Against TB and Lung Disease, has a critical role in reducing the worldwide burden of disease and thus in protecting children from infection and disease. The management of children with TB should be in line with the Stop TB Strategy, taking into consideration the particular epidemiology and clinical presentation of TB in children. These consensus guidelines were produced to help the National Tuberculosis Programmes on the management of tuberculosis in children.
Author: World Health Organization
Publisher:
ISBN: 9789241548748
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
It is estimated that one third of the world's population is infected with Mycobacterium tuberculosis (the bacterium that causes tuberculosis (TB)), and that each year, about 9 million people develop TB, of whom about 2 million die. Of the 9 million annual TB cases, about 1 million (11%) occur in children (under 15 years of age). Of these childhood cases, 75% occur annually in 22 high-burden countries that together account for 80% of the world's estimated incident cases. In countries worldwide, the reported percentage of all TB cases occurring in children varies from 3% to more than 25%. The Stop TB Strategy, which builds on the DOTS strategy developed by the World Health Organization (WHO) and the International Union Against TB and Lung Disease, has a critical role in reducing the worldwide burden of disease and thus in protecting children from infection and disease. The management of children with TB should be in line with the Stop TB Strategy, taking into consideration the particular epidemiology and clinical presentation of TB in children. These consensus guidelines were produced to help the National Tuberculosis Programmes on the management of tuberculosis in children.
Author: William R. Jacobs, Jr.
Publisher: John Wiley & Sons
ISBN: 1683673050
Category : Medical
Languages : en
Pages : 1379
Get Book Here
Book Description
Can today's innovative practices and molecular tools tame this ancient disease? One third of the world's population is infected with tuberculosis (TB), with about 10 million new cases annually. To combat TB and its agent, Mycobacterium tuberculosis, the World Health Organization launched The End TB Strategy, which aims to slash the suffering and cost of TB by 2035. This makes the second edition of Tuberculosis and the Tubercle Bacillus, edited by Jacobs, McShane, Mizrahi, and Orme, an extremely valuable resource for scientists and clinicians. The editors have gathered their colleagues from around the world to present the latest on the molecular biology of M. tuberculosis and related species, the host-pathogen interactions that enable invasion, and the host's immune response to M. tuberculosis infection. The basic, clinical, and translational research presented in this book supports the goals of WHO's End TB Strategy by driving toward the development of effective vaccines, rapid molecular diagnostics, and anti-TB drugs. Creating an effective tuberculosis vaccine. Understand the innate and adaptive immune response to M. tuberculosis infection, its study in established animal models, and how this information is being used to develop new vaccines against TB. Formulating new antituberculosis drugs. Learn the challenges and methods for evaluating new drugs in preclinical trials with a focus on drugs that work against "persisters" and those that act on the electron transport complex and ATP synthase of M. tuberculosis. Overcoming the challenges of diagnosing tuberculosis. Review new diagnostic tools that are simple, rapid, affordable, specific, sensitive, and safe, including molecular-based diagnostic methods such as GeneXpert MTB/RIF. Using molecular, genomic, and bioinformatics tools to understand the biology and evolution of Mycobacterium. Explore current research on the molecular mechanisms that M. tuberculosis uses to evade the immune system, enter a state of nonreplicating persistence, and become reactivated. The second edition of Tuberculosis and the Tubercle Bacillus presents the latest research on a microorganism that is exquisitely well adapted to its human host. This pathogen continues to confound scientists, clinicians, and public health specialists, who will all find much valuable information in this comprehensive set of reviews.
Author: King K. Holmes
Publisher: World Bank Publications
ISBN: 1464805253
Category : Medical
Languages : en
Pages : 1027
Get Book Here
Book Description
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.
Author: K. Toman
Publisher: World Health Organization
ISBN: 9241546034
Category : Medical
Languages : en
Pages : 350
Get Book Here
Book Description
This is the second edition of a reference work aimed at all those concerned with dealing with tuberculosis control in developing countries. The book follows in the tradition of Kurt Toman's original work in this field, with the text set out in a question and answer format, grouped under three headings: case detection; treatment, and monitoring. The threat of tuberculosis is still potent, with two million deaths globally. This new edition, containing contributions from a number of experts in this field, addresses the resurgence of tuberculosis, and the emergence of multidrug-resistant bacilli, and the growth of HIV-infected individuals with tuberculosis, as well as recent scientific developments.
Author: World Health Organization
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 60
Get Book Here
Book Description
Author: Charles O. Thoen
Publisher: John Wiley & Sons
ISBN: 0470344156
Category : Medical
Languages : en
Pages : 356
Get Book Here
Book Description
Written by tuberculosis specialists from around the world, Mycobacterium Bovis Infection in Animals and Humans, Second Edition remains the most comprehensive collection of timely information regarding Mycobacterium bovis in any single source. The chapters are organized for quick access to well-indexed topics, and extensive reference lists are included to aid infectious disease specialists, regulatory officials, diagnosticians, researchers or public health workers interested in M bovis. This international reference includes the most current information on mechanisms of virulence of tubercle bacilli and immunologic and biochemical responses of the host involved in resistance. The book includes information on the diagnosis and application of the latest molecular techniques in epidemiologic investigations. Included are chapters on the economic impact of outbreaks of M. bovis in alternate species on control programs in domestic animals. There are also contributions by representatives of the International Union Against Tuberculosis and Lung Disease, PAHO of the World Health Organization, The Centers for Disease Control, and The University of Texas Health Center. This excellent reference is an invaluable aid to clinicians dealing directly with tuberculosis, as well as to government regulatory personnel, professional and graduate students, and instructors in basic and allied health sciences
Author: Diane Yancey
Publisher: Twenty-First Century Books
ISBN: 0761340424
Category : Young Adult Nonfiction
Languages : en
Pages : 132
Get Book Here
Book Description
One of the deadliest diseases healthcare workers fight today, tuberculosis (often called TB) infects the lungs of one-third of the world’s population and kills about 2 million people a year. While scientific breakthroughs brought this bacterial disease under control during the 1960s to the 1980s, it was never completely eliminated. In the early 1990s, TB came back as a serious global threat. Not only has TB now spread to virtually every country on Earth, new strains of TB—which are resistant to the standard antibiotics used to cure it—have appeared. Learn what causes TB, how it spreads, why it is so difficult to treat, and more in this informative volume.
Author: Giovanni Battista Migliori
Publisher: Springer Nature
ISBN: 3030667030
Category : Medical
Languages : en
Pages : 416
Get Book Here
Book Description
This textbook covers the full spectrum of tuberculosis-related topics in a comprehensive yet easy-to-follow, readily accessible format. Filling a significant gap in tuberculosis literature, it addresses tuberculosis sensu latu, mirroring the content of the London Queen Mary University tuberculosis Diploma. Covering all aspects related to this condition, from prevention, diagnosis and treatment to public and global health, the book provides a broad overview of tuberculosis management. Further, it includes a wealth of case studies and exercises, making it an essential guide for all staff involved in tuberculosis management. Written by an international and interdisciplinary panel of experts, the book appeals to a broad readership including students, postdoctoral fellows, clinicians, researchers, and nurses, as well as public health officers working in tuberculosis control programs.
Author: Lloyd N. Friedman
Publisher: CRC Press
ISBN: 1420039954
Category : Medical
Languages : en
Pages : 535
Get Book Here
Book Description
Why is tuberculosis out of control? What prompted a change in U.S. health policy? In the revised edition of the 1994 book, the editor has updated his bestseller to address the new challenge tuberculosis is presenting to both the medical community and the general public. The emphasis in the United States has changed to directly observe
Author: Mario C. Raviglione
Publisher: CRC Press
ISBN: 1420090232
Category : Medical
Languages : en
Pages : 408
Get Book Here
Book Description
Every second a new person is exposed to tuberculosis (TB). Each untreated TB-infected person will infect 10-15 people every year. Following the success of its predecessor, this new edition of Tuberculosis: The Essentials scrutinizes the new discoveries and observations of the key aspects of the disease. Recognized world experts provide a concise, state-of-the-art review of the 15 essential elements of TBsupply an international, current view of the epidemiology, pathophysiology, diagnosis, and treatment methodsdiscuss the emerging threat of XDR-TB and the HIV/AIDS factorassess advances in TB research such as new drugs and vaccinesreflect on the progress of the "Stop TB" strategy.
